The high-sensitivity C-reactive protein to albumin ratio (CAR) or C-reactive protein to albumin has emerged as a valuable prognostic indicator in various medical conditions including solid tumors, hematological malignancies, cardiovascular diseases and respiratory diseases [16–20]. This evidence concerns the gene ALB and hematologic disorder.